International Journal of Cardiology

Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-Americas.  352:78-83. 2022

Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.  339:47-53. 2021

Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction.  335:59-65. 2021

Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinib.  316:214-221. 2020

Angiotensin-(1–12)/chymase axis modulates cardiomyocyte L-type calcium currents in rats expressing human angiotensinogen.  297:104-110. 2019

“Treat-to-close”: Non-repairable ASD-PAH in the adult: Results from the North American ASD-PAH (NAAP) Multicenter Registry.  291:127-133. 2019

Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.  286:145-151. 2019

Clinical correlates and heritability of cardiac mechanics: The HyperGEN study.  274:208-213. 2019

Incidence and in-hospital outcomes of single-vessel coronary chronic total occlusion treated with percutaneous coronary intervention.  269:61-66. 2018

Comparison of carotid plaque burden among healthy middle-aged men living in the US, Japan, and South Korea.  266:245-249. 2018

Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.  259:145-152. 2018

Glycogen synthase kinase 3β helps heart to pump better in obese patients.  259:166-167. 2018

FFR-guided multivessel stenting reduces urgent revascularization compared with infarct-related artery only stenting in ST-elevation myocardial infarction: A meta-analysis of randomized controlled trials.  252:63-67. 2018

Prognostic value of silent myocardial infarction in patients with chronic kidney disease being evaluated for kidney transplantation.  249:377-382. 2017

Corrigendum to “Systolic–diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study” [Int. J. Cardiol. 235 (2017) 11–16] (S0167527317312901) (10.1016/j.ijcard.2017.02.139)).  238:181. 2017

Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study.  238:140-143. 2017

Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.  236:462-465. 2017

Systolic–diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.  235:11-16. 2017

Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.  227:808-812. 2017

Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.  227:462-466. 2017

Abnormal autonomic nervous system function in rural Thai men: A potential contributor to their high risk of sudden unexplained nocturnal death syndrome.  226:87-92. 2017

Catheter-directed treatment for acute pulmonary embolism: Systematic review and single-arm meta-analyses.  225:128-139. 2016

Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: Insights from meta-analysis of randomized and observational studies.  221:601-608. 2016

Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.  220:122-128. 2016

What is the association of lipid levels and incident stroke?.  220:890-894. 2016

Does chemo-radiation predispose to structural valve deterioration?.  211:53-54. 2016

Healthy lifestyle factors and incident heart disease and mortality in candidates for primary prevention with statin therapy.  207:196-202. 2016

Depletion of cardiac 14-3-3η protein adversely influences pathologic cardiac remodeling during myocardial infarction after coronary artery ligation in mice.  202:146-153. 2016

Paroxysmal atrial fibrillation and the hazards of under-treatment.  202:214-220. 2016

Association between cumulative social risk and ideal cardiovascular health in US adults: NHANES 1999-2006.  191:296-300. 2015

Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors - Results from a systematic review and meta-analysis of randomized controlled trials.  189:47-55. 2015

Glycoprotein IIb/IIIa inhibitors improve mortality after aspiration thrombectomy in patients with ST-segment elevation myocardial infarction.  187:206-207. 2015

Non-linear association of periodontal pathogen antibodies with mortality.  187:628-636. 2015

Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  185:219-223. 2015

Comparison between saddle versus non-saddle pulmonary embolism: Insights from nationwide inpatient sample.  180:58-59. 2015

Lack of "weekend effect" on mortality for pulmonary embolism admissions in 2011: Data from nationwide inpatient sample.  180:151-153. 2015

Analysis of vitamin D levels in patients with and without statin-associated myalgia - A systematic review and meta-analysis of 7 studies with 2420 patients.  178:111-116. 2015

One-year outcome following biological or mechanical valve replacement for infective endocarditis.  178:117-123. 2015

Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial.  184:446-451. 2015

Simple physical performance measures and vascular health in late midlife women: The Study of Women's Health Across the Nation.  182:115-120. 2015

Success of left ventricular assist device therapy in uninsured patients.  177:1087-1088. 2014

Racial differences in mortality in patients with advanced systolic heart failure: Potential role of right ventricular ejection fraction.  177:255-260. 2014

Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart disease.  174:436-439. 2014

Beta-blockers in older patients with heart failure and preserved ejection fraction: Class, dosage, and outcomes.  173:393-401. 2014

Framingham score and LV mass predict events in young adults: CARDIA study.  172:350-355. 2014

Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication.  176:219-226. 2014

Anthrax lethal toxin induces acute diastolic dysfunction in rats through disruption of the phospholamban signaling network.  168:3884-3895. 2013

Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study.  168:3764-3769. 2013

Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: Findings from a population-based cohort study.  168:3616-3622. 2013

Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: The NHLBI-sponsored Women's Ischemia Syndrome Evaluation.  168:2335-2340. 2013

Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events.  168:1905-1909. 2013

Caveolin and β1-integrin coordinate angiotensinogen expression in cardiac myocytes.  168:436-445. 2013

Impact of diabetes on long-term mortality following multivessel percutaneous interventions: An insight into optimal statistical analysis.  167:2120-2125. 2013

Takotsubo cardiomyopathy versus ST-elevation myocardial infarction in a large case-control study: Proposing a New Mechanism.  167:1079-1081. 2013

Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: Insights from the SOLVD Treatment trial.  167:151-156. 2013

Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data.  166:230-235. 2013

Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: Primary versus secondary prevention.  165:113-116. 2013

Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving beta-blockers: Insights from the BEST trial.  163:61-67. 2013

The heart rate response to adenosine: A simple predictor of adverse cardiac outcomes in asymptomatic patients with type 2 diabetes.  167:2952-2957. 2013

Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: Findings from the Alabama Heart Failure Project.  162:39-44. 2012

Ventricular assist devices: Bridge to continued employment.  158:468. 2012

The decline in coronary heart disease mortality is slowing in young adults (Australia 1976-2006): A time trend analysis.  158:193-198. 2012

Circulating carboxy-terminal propeptide of type i procollagen is increased in rheumatic heart disease.  156:117-119. 2012

Right ventricular ejection fraction b20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients.  155:120-125. 2012

The role of echocardiography in the evaluation and management of aortic stenosis in the older adult.  155:39-48. 2012

Outcomes in younger and older adults with chronic advanced systolic heart failure: A propensity-matched study.  154:128-133. 2012

High risk closure of a large secundum ASD causing platypnea-orthodeoxia.  152. 2011

Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure.  151:69-75. 2011

Self-reported teenage body size and heart failure in adults ≥ 65 years of age.  149:401-402. 2011

Gender-related dissociation in outcomes in chronic heart failure: Reduced mortality but similar hospitalization in women.  148:36-42. 2011

Epidemiology of stroke in chronic heart failure patients with normal sinus rhythm: Findings from the DIG stroke sub-study.  144:389-393. 2010

Mild hyperkalemia and outcomes in chronic heart failure: A propensity matched study.  144:383-388. 2010

Association between hyperuricemia and incident heart failure among older adults: A propensity-matched study.  142:279-287. 2010

Oral potassium supplement use and outcomes in chronic heart failure: A propensity-matched study.  141:167-174. 2010

Incident coronary revascularization and subsequent mortality in chronic heart failure: A propensity-matched study.  140:55-59. 2010

Erratum to "Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: A propensity-matched study of multimorbidity in chronic heart failure" [Int. J. Cardiol. 134 (2009) 330-335] (DOI:10.1016/j.ijcard.2008.12.089).  138:106. 2010

Aspirated air in the pericardial space during epicardial catheterization may elevate the defibrillation threshold.  135. 2009

Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: A propensity-matched study of multimorbidity in chronic heart failure.  134:330-335. 2009

Takotsubo cardiomyopathy - A new variant and widening disease spectrum. "Inverted takotsubo" pattern related to catecholamine toxicity.  132:438-439. 2009

Richard Lower (1631-1691) and his early contributions to cardiology.  128:17-21. 2008

Takotsubo cardiomyopathy - A new variant and widening disease spectrum.  120. 2007

Restenosis is associated with decreased coronary artery nitric oxide synthase.  55:183-191. 1996

Exaggerated systolic blood pressure response to exercise: a normal variant or a hyperdynamic phase of essential hypertension?.  18:207-221. 1988

Prognostic implications of rest and exercise radionuclide ventriculography in patients with suspected or proven coronary heart disease.  6:707-718. 1984

Effects of verapamil on automaticity and conduction with particular reference to tachyphylaxis.  9:345-368. 1979